Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BonoFill-II in bone fracture and defect regeneration
NCT03024008Phase 2Recruiting
- Sponsor
- Bonus BioGroup
- Start
- Jul 2017
- Primary completion
- Mar 2027
- Modality
- Implantable Devices, Implantable Hydrogels, Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of BonoFill-II in bone fracture (Fx), Bone defect, nonunion, sponsored by Bonus BioGroup. Started Jul 2017; status: recruiting.
02
Drugs
BonoFill-II
03
Conditions
bone fracture (Fx)Bone defectnonunion
Beyond the preview
Go deeper on NCT03024008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03024008.